These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9340574)

  • 41. [The alimentary correction of dyslipoproteinemias in children with a hereditary risk for ischemic heart disease].
    Peradze MB; Kvachadze IM; Uberi NP; Gus'kova VS
    Vopr Pitan; 1992; (5-6):22-5. PubMed ID: 1296358
    [No Abstract]   [Full Text] [Related]  

  • 42. [The prevalence of hyperlipoproteidemia and hyperglicemia in males covered by the Polish trial on prevention of ischaemic heart disease (author's transl)].
    Chotkowska E; Szostak WB; Rywik S; Wasowicz B; Magdoń M; Celiński A
    Przegl Lek; 1979; 36(10):743-8. PubMed ID: 515459
    [No Abstract]   [Full Text] [Related]  

  • 43. What can human genetics teach us about the causes of cardiovascular disease?
    Newton-Cheh C; Smith JG
    J Am Coll Cardiol; 2010 Jun; 55(25):2843-5. PubMed ID: 20579541
    [No Abstract]   [Full Text] [Related]  

  • 44. Apolipoproteins: significance for lipid metabolism and for diagnosis of atherosclerotic disease.
    Kostner GM; Wurm H; Zechner R; Pilger E; Dieplinger H
    Prog Clin Biol Res; 1985; 188():67-77. PubMed ID: 4059260
    [No Abstract]   [Full Text] [Related]  

  • 45. [Apolipoproteins in the evaluation of familial susceptibility to atherosclerosis].
    Jirkovská A; Válek J; Grafnetter D; Vondra K; Skibová J
    Cas Lek Cesk; 1984 Feb; 123(5):130-2. PubMed ID: 6697360
    [No Abstract]   [Full Text] [Related]  

  • 46. [The determination of apolipoproteins. Its possible diagnostic importance].
    Titov VN; Tvorogova MG
    Ter Arkh; 1992; 64(6):115-9. PubMed ID: 1440326
    [No Abstract]   [Full Text] [Related]  

  • 47. [Genes, dyslipoproteinemias and atherosclerosis: from the experimental to the therapeutic].
    Fruchart JC; Duriez P
    Ann Endocrinol (Paris); 1999 Sep; 60(3):175-6. PubMed ID: 10520406
    [No Abstract]   [Full Text] [Related]  

  • 48. [Apolipoprotein(a)--a marker of the atherosclerotic process].
    Titov VN
    Ter Arkh; 1993; 65(12):79-82. PubMed ID: 7511838
    [No Abstract]   [Full Text] [Related]  

  • 49. [Classification of disorders of lipid metabolism].
    Richter WO; Schwandt P
    Internist (Berl); 1992 Nov; 33(11):728-31. PubMed ID: 1478827
    [No Abstract]   [Full Text] [Related]  

  • 50. [The psychological characteristics of adolescents with ischemic heart disease in their anamnesis and their linkage to the lipoprotein spectrum indices].
    Leont'eva IV; Metel'skaia VA; Sipiagina AE; Dobrynina MV; Aĭngorn ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(3):51-5. PubMed ID: 7975990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutants of apolipoproteins A and C.
    Sirtori CR; Lovati MR
    Verh Dtsch Ges Inn Med; 1986; 92():403-12. PubMed ID: 3811541
    [No Abstract]   [Full Text] [Related]  

  • 52. [Familial and genetic factors in lipoproteinemia disorders].
    Sova J
    Cas Lek Cesk; 1984 Jun; 123(25):753-7. PubMed ID: 6467322
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hyperlipoproteinemia mass screening in a pediatric patient group].
    László A; Joó I; Turi S
    Kinderarztl Prax; 1982 Oct; 50(10):506-17. PubMed ID: 7154521
    [No Abstract]   [Full Text] [Related]  

  • 54. [Importance of the occupational factor in the realization of influences that induce atherogenic disorders of lipid metabolism].
    Bel'chenko DI; Aleksenko AS; Khanina NIa; Domanskiĭ VIu; Pokrovskiĭ EA
    Kardiologiia; 1980 Mar; 20(3):76-80. PubMed ID: 6445436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hereditary predisposition to arteriosclerosis].
    Il'inskiĭ BV; Kliueva SK
    Vestn Akad Med Nauk SSSR; 1973; 28(2):88-94. PubMed ID: 4774036
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hyperlipoprotein phenotypes as risk factors in ischemic heart disease. I. General aspects].
    Walter-Roşianu A
    Rev Pediatr Obstet Ginecol Pediatr; 1984; 33(1):37-45. PubMed ID: 6426019
    [No Abstract]   [Full Text] [Related]  

  • 57. [Familial hyperlipoproteinemia and dyslipoproteinemia].
    Sobra J
    Sb Lek; 1995; 96(4):371-4. PubMed ID: 8711386
    [No Abstract]   [Full Text] [Related]  

  • 58. [Symptomatologic value of apolipoproteins].
    Fruchart JC
    Rev Med Interne; 1985 Jan; 6(1):41-8. PubMed ID: 3890047
    [No Abstract]   [Full Text] [Related]  

  • 59. LDL density and atherosclerosis.
    Austin MA; Krauss RM
    JAMA; 1995 Jan; 273(2):115. PubMed ID: 7799488
    [No Abstract]   [Full Text] [Related]  

  • 60. Lewis phenotypes, insulin resistance, and risk of ischaemic heart disease.
    Meeran K; Bloom SR
    Br Heart J; 1994 Apr; 71(4):305-6. PubMed ID: 8198876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.